The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Canine Influenza Vaccine Market Research Report 2025
Synopsis
Canine influenza is influenza occurring in canine animals. Canine influenza is caused by varieties of influenzavirus A, such as equine influenza virus H3N8, which was discovered to cause disease in canines in 2004. Because of the lack of previous exposure to this virus, dogs have no natural immunity to it. Therefore, the disease is rapidly transmitted between individual dogs. Canine influenza may be endemic in some regional dog populations of the United States. It is a disease with a high morbidity but a low incidence of death.
The global Canine Influenza Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Canine Influenza Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Canine Influenza Vaccine.
Report Scope
The Canine Influenza Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Canine Influenza Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Canine Influenza Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bharat Biotech
GSK
Novartis
Merck Animal Health
Roche
Zoetis
CSL Limited
CNBG
LIAONING CHENGDA
Segment by Type
H3N2 Vaccine
H3N8 Vaccine
Segment by Application
Vaccination Clinic
Pet Hospital
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Canine Influenza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Canine Influenza Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Canine influenza is influenza occurring in canine animals. Canine influenza is caused by varieties of influenzavirus A, such as equine influenza virus H3N8, which was discovered to cause disease in canines in 2004. Because of the lack of previous exposure to this virus, dogs have no natural immunity to it. Therefore, the disease is rapidly transmitted between individual dogs. Canine influenza may be endemic in some regional dog populations of the United States. It is a disease with a high morbidity but a low incidence of death.
The global Canine Influenza Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Canine Influenza Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Canine Influenza Vaccine.
Report Scope
The Canine Influenza Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Canine Influenza Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Canine Influenza Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bharat Biotech
GSK
Novartis
Merck Animal Health
Roche
Zoetis
CSL Limited
CNBG
LIAONING CHENGDA
Segment by Type
H3N2 Vaccine
H3N8 Vaccine
Segment by Application
Vaccination Clinic
Pet Hospital
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Canine Influenza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Canine Influenza Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Canine Influenza Vaccine Market Overview
1.1 Product Overview and Scope of Canine Influenza Vaccine
1.2 Canine Influenza Vaccine Segment by Type
1.2.1 Global Canine Influenza Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 H3N2 Vaccine
1.2.3 H3N8 Vaccine
1.3 Canine Influenza Vaccine Segment by Application
1.3.1 Global Canine Influenza Vaccine Market Value by Application: (2024-2030)
1.3.2 Vaccination Clinic
1.3.3 Pet Hospital
1.3.4 Others
1.4 Global Canine Influenza Vaccine Market Size Estimates and Forecasts
1.4.1 Global Canine Influenza Vaccine Revenue 2019-2030
1.4.2 Global Canine Influenza Vaccine Sales 2019-2030
1.4.3 Global Canine Influenza Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Canine Influenza Vaccine Market Competition by Manufacturers
2.1 Global Canine Influenza Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Canine Influenza Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Canine Influenza Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Canine Influenza Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Canine Influenza Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Canine Influenza Vaccine, Product Type & Application
2.7 Canine Influenza Vaccine Market Competitive Situation and Trends
2.7.1 Canine Influenza Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Canine Influenza Vaccine Players Market Share by Revenue
2.7.3 Global Canine Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Canine Influenza Vaccine Retrospective Market Scenario by Region
3.1 Global Canine Influenza Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Canine Influenza Vaccine Global Canine Influenza Vaccine Sales by Region: 2019-2030
3.2.1 Global Canine Influenza Vaccine Sales by Region: 2019-2024
3.2.2 Global Canine Influenza Vaccine Sales by Region: 2025-2030
3.3 Global Canine Influenza Vaccine Global Canine Influenza Vaccine Revenue by Region: 2019-2030
3.3.1 Global Canine Influenza Vaccine Revenue by Region: 2019-2024
3.3.2 Global Canine Influenza Vaccine Revenue by Region: 2025-2030
3.4 North America Canine Influenza Vaccine Market Facts & Figures by Country
3.4.1 North America Canine Influenza Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Canine Influenza Vaccine Sales by Country (2019-2030)
3.4.3 North America Canine Influenza Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Canine Influenza Vaccine Market Facts & Figures by Country
3.5.1 Europe Canine Influenza Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Canine Influenza Vaccine Sales by Country (2019-2030)
3.5.3 Europe Canine Influenza Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Canine Influenza Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Canine Influenza Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Canine Influenza Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Canine Influenza Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Canine Influenza Vaccine Market Facts & Figures by Country
3.7.1 Latin America Canine Influenza Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Canine Influenza Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Canine Influenza Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Canine Influenza Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Canine Influenza Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Canine Influenza Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Canine Influenza Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Canine Influenza Vaccine Sales by Type (2019-2030)
4.1.1 Global Canine Influenza Vaccine Sales by Type (2019-2024)
4.1.2 Global Canine Influenza Vaccine Sales by Type (2025-2030)
4.1.3 Global Canine Influenza Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Canine Influenza Vaccine Revenue by Type (2019-2030)
4.2.1 Global Canine Influenza Vaccine Revenue by Type (2019-2024)
4.2.2 Global Canine Influenza Vaccine Revenue by Type (2025-2030)
4.2.3 Global Canine Influenza Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Canine Influenza Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Canine Influenza Vaccine Sales by Application (2019-2030)
5.1.1 Global Canine Influenza Vaccine Sales by Application (2019-2024)
5.1.2 Global Canine Influenza Vaccine Sales by Application (2025-2030)
5.1.3 Global Canine Influenza Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Canine Influenza Vaccine Revenue by Application (2019-2030)
5.2.1 Global Canine Influenza Vaccine Revenue by Application (2019-2024)
5.2.2 Global Canine Influenza Vaccine Revenue by Application (2025-2030)
5.2.3 Global Canine Influenza Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Canine Influenza Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bharat Biotech
6.1.1 Bharat Biotech Corporation Information
6.1.2 Bharat Biotech Description and Business Overview
6.1.3 Bharat Biotech Canine Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bharat Biotech Canine Influenza Vaccine Product Portfolio
6.1.5 Bharat Biotech Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Canine Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Canine Influenza Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Canine Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Canine Influenza Vaccine Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Merck Animal Health
6.4.1 Merck Animal Health Corporation Information
6.4.2 Merck Animal Health Description and Business Overview
6.4.3 Merck Animal Health Canine Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Animal Health Canine Influenza Vaccine Product Portfolio
6.4.5 Merck Animal Health Recent Developments/Updates
6.5 Roche
6.5.1 Roche Corporation Information
6.5.2 Roche Description and Business Overview
6.5.3 Roche Canine Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Roche Canine Influenza Vaccine Product Portfolio
6.5.5 Roche Recent Developments/Updates
6.6 Zoetis
6.6.1 Zoetis Corporation Information
6.6.2 Zoetis Description and Business Overview
6.6.3 Zoetis Canine Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Zoetis Canine Influenza Vaccine Product Portfolio
6.6.5 Zoetis Recent Developments/Updates
6.7 CSL Limited
6.6.1 CSL Limited Corporation Information
6.6.2 CSL Limited Description and Business Overview
6.6.3 CSL Limited Canine Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CSL Limited Canine Influenza Vaccine Product Portfolio
6.7.5 CSL Limited Recent Developments/Updates
6.8 CNBG
6.8.1 CNBG Corporation Information
6.8.2 CNBG Description and Business Overview
6.8.3 CNBG Canine Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CNBG Canine Influenza Vaccine Product Portfolio
6.8.5 CNBG Recent Developments/Updates
6.9 LIAONING CHENGDA
6.9.1 LIAONING CHENGDA Corporation Information
6.9.2 LIAONING CHENGDA Description and Business Overview
6.9.3 LIAONING CHENGDA Canine Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 LIAONING CHENGDA Canine Influenza Vaccine Product Portfolio
6.9.5 LIAONING CHENGDA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Canine Influenza Vaccine Industry Chain Analysis
7.2 Canine Influenza Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Canine Influenza Vaccine Production Mode & Process
7.4 Canine Influenza Vaccine Sales and Marketing
7.4.1 Canine Influenza Vaccine Sales Channels
7.4.2 Canine Influenza Vaccine Distributors
7.5 Canine Influenza Vaccine Customers
8 Canine Influenza Vaccine Market Dynamics
8.1 Canine Influenza Vaccine Industry Trends
8.2 Canine Influenza Vaccine Market Drivers
8.3 Canine Influenza Vaccine Market Challenges
8.4 Canine Influenza Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Canine Influenza Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Canine Influenza Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Canine Influenza Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Canine Influenza Vaccine Sales (K Doses) of Key Manufacturers (2019-2024)
Table 5. Global Canine Influenza Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Canine Influenza Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Canine Influenza Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Canine Influenza Vaccine Average Price (USD/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Canine Influenza Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Canine Influenza Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Canine Influenza Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Canine Influenza Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Canine Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Influenza Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Canine Influenza Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Canine Influenza Vaccine Sales by Region (2019-2024) & (K Doses)
Table 18. Global Canine Influenza Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Canine Influenza Vaccine Sales by Region (2025-2030) & (K Doses)
Table 20. Global Canine Influenza Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Canine Influenza Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Canine Influenza Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Canine Influenza Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Canine Influenza Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Canine Influenza Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Canine Influenza Vaccine Sales by Country (2019-2024) & (K Doses)
Table 27. North America Canine Influenza Vaccine Sales by Country (2025-2030) & (K Doses)
Table 28. North America Canine Influenza Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Canine Influenza Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Canine Influenza Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Canine Influenza Vaccine Sales by Country (2019-2024) & (K Doses)
Table 32. Europe Canine Influenza Vaccine Sales by Country (2025-2030) & (K Doses)
Table 33. Europe Canine Influenza Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Canine Influenza Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Canine Influenza Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Canine Influenza Vaccine Sales by Region (2019-2024) & (K Doses)
Table 37. Asia Pacific Canine Influenza Vaccine Sales by Region (2025-2030) & (K Doses)
Table 38. Asia Pacific Canine Influenza Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Canine Influenza Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Canine Influenza Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Canine Influenza Vaccine Sales by Country (2019-2024) & (K Doses)
Table 42. Latin America Canine Influenza Vaccine Sales by Country (2025-2030) & (K Doses)
Table 43. Latin America Canine Influenza Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Canine Influenza Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Canine Influenza Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Canine Influenza Vaccine Sales by Country (2019-2024) & (K Doses)
Table 47. Middle East & Africa Canine Influenza Vaccine Sales by Country (2025-2030) & (K Doses)
Table 48. Middle East & Africa Canine Influenza Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Canine Influenza Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Canine Influenza Vaccine Sales (K Doses) by Type (2019-2024)
Table 51. Global Canine Influenza Vaccine Sales (K Doses) by Type (2025-2030)
Table 52. Global Canine Influenza Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Canine Influenza Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Canine Influenza Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Canine Influenza Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Canine Influenza Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Canine Influenza Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Canine Influenza Vaccine Price (USD/Dose) by Type (2019-2024)
Table 59. Global Canine Influenza Vaccine Price (USD/Dose) by Type (2025-2030)
Table 60. Global Canine Influenza Vaccine Sales (K Doses) by Application (2019-2024)
Table 61. Global Canine Influenza Vaccine Sales (K Doses) by Application (2025-2030)
Table 62. Global Canine Influenza Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Canine Influenza Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Canine Influenza Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Canine Influenza Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Canine Influenza Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Canine Influenza Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Canine Influenza Vaccine Price (USD/Dose) by Application (2019-2024)
Table 69. Global Canine Influenza Vaccine Price (USD/Dose) by Application (2025-2030)
Table 70. Bharat Biotech Corporation Information
Table 71. Bharat Biotech Description and Business Overview
Table 72. Bharat Biotech Canine Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 73. Bharat Biotech Canine Influenza Vaccine Product
Table 74. Bharat Biotech Recent Developments/Updates
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Canine Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 78. GSK Canine Influenza Vaccine Product
Table 79. GSK Recent Developments/Updates
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Canine Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 83. Novartis Canine Influenza Vaccine Product
Table 84. Novartis Recent Developments/Updates
Table 85. Merck Animal Health Corporation Information
Table 86. Merck Animal Health Description and Business Overview
Table 87. Merck Animal Health Canine Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 88. Merck Animal Health Canine Influenza Vaccine Product
Table 89. Merck Animal Health Recent Developments/Updates
Table 90. Roche Corporation Information
Table 91. Roche Description and Business Overview
Table 92. Roche Canine Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 93. Roche Canine Influenza Vaccine Product
Table 94. Roche Recent Developments/Updates
Table 95. Zoetis Corporation Information
Table 96. Zoetis Description and Business Overview
Table 97. Zoetis Canine Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 98. Zoetis Canine Influenza Vaccine Product
Table 99. Zoetis Recent Developments/Updates
Table 100. CSL Limited Corporation Information
Table 101. CSL Limited Description and Business Overview
Table 102. CSL Limited Canine Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 103. CSL Limited Canine Influenza Vaccine Product
Table 104. CSL Limited Recent Developments/Updates
Table 105. CNBG Corporation Information
Table 106. CNBG Description and Business Overview
Table 107. CNBG Canine Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 108. CNBG Canine Influenza Vaccine Product
Table 109. CNBG Recent Developments/Updates
Table 110. LIAONING CHENGDA Corporation Information
Table 111. LIAONING CHENGDA Description and Business Overview
Table 112. LIAONING CHENGDA Canine Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 113. LIAONING CHENGDA Canine Influenza Vaccine Product
Table 114. LIAONING CHENGDA Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Canine Influenza Vaccine Distributors List
Table 118. Canine Influenza Vaccine Customers List
Table 119. Canine Influenza Vaccine Market Trends
Table 120. Canine Influenza Vaccine Market Drivers
Table 121. Canine Influenza Vaccine Market Challenges
Table 122. Canine Influenza Vaccine Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Canine Influenza Vaccine
Figure 2. Global Canine Influenza Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Canine Influenza Vaccine Market Share by Type in 2023 & 2030
Figure 4. H3N2 Vaccine Product Picture
Figure 5. H3N8 Vaccine Product Picture
Figure 6. Global Canine Influenza Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Canine Influenza Vaccine Market Share by Application in 2023 & 2030
Figure 8. Vaccination Clinic
Figure 9. Pet Hospital
Figure 10. Others
Figure 11. Global Canine Influenza Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Canine Influenza Vaccine Market Size (2019-2030) & (US$ Million)
Figure 13. Global Canine Influenza Vaccine Sales (2019-2030) & (K Doses)
Figure 14. Global Canine Influenza Vaccine Average Price (USD/Dose) & (2019-2030)
Figure 15. Canine Influenza Vaccine Report Years Considered
Figure 16. Canine Influenza Vaccine Sales Share by Manufacturers in 2023
Figure 17. Global Canine Influenza Vaccine Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Canine Influenza Vaccine Players: Market Share by Revenue in 2023
Figure 19. Canine Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Canine Influenza Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Canine Influenza Vaccine Sales Market Share by Country (2019-2030)
Figure 22. North America Canine Influenza Vaccine Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Canine Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Canine Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Canine Influenza Vaccine Sales Market Share by Country (2019-2030)
Figure 26. Europe Canine Influenza Vaccine Revenue Market Share by Country (2019-2030)
Figure 27. Germany Canine Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Canine Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Canine Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Canine Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Canine Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Canine Influenza Vaccine Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Canine Influenza Vaccine Revenue Market Share by Region (2019-2030)
Figure 34. China Canine Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Canine Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Canine Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Canine Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Canine Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Canine Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Canine Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Canine Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Canine Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Canine Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Canine Influenza Vaccine Sales Market Share by Country (2019-2030)
Figure 45. Latin America Canine Influenza Vaccine Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Canine Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Canine Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Canine Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Canine Influenza Vaccine Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Canine Influenza Vaccine Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Canine Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Canine Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Canine Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Canine Influenza Vaccine by Type (2019-2030)
Figure 55. Global Revenue Market Share of Canine Influenza Vaccine by Type (2019-2030)
Figure 56. Global Canine Influenza Vaccine Price (USD/Dose) by Type (2019-2030)
Figure 57. Global Sales Market Share of Canine Influenza Vaccine by Application (2019-2030)
Figure 58. Global Revenue Market Share of Canine Influenza Vaccine by Application (2019-2030)
Figure 59. Global Canine Influenza Vaccine Price (USD/Dose) by Application (2019-2030)
Figure 60. Canine Influenza Vaccine Value Chain
Figure 61. Canine Influenza Vaccine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
